Sinopharm Group Co Ltd
HKEX:1099
Relative Value
The Relative Value of one Sinopharm Group Co Ltd stock under the Base Case scenario is 109.66 HKD. Compared to the current market price of 20.2 HKD, Sinopharm Group Co Ltd is Undervalued by 82%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Sinopharm Group Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
62.2B HKD | 0.1 | 6.4 | 1.5 | 1.8 | ||
US |
Mckesson Corp
NYSE:MCK
|
69.3B USD | 0.2 | 23.1 | 16.1 | 18.7 | ||
US |
Cencora Inc
NYSE:COR
|
44.7B USD | 0.2 | 24.1 | 16.7 | 16.7 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.1B USD | 0.1 | 37.8 | 8.4 | 11.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 0.7 | 21.1 | 11.2 | 15 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
58.9B CNY | 1.5 | 21.8 | 15.9 | 15.9 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.1B EUR | 3.2 | 45.9 | 14.8 | 29.2 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |